23 / 43
Treatment free survival (TFS) in IMDC intermediate/poor-
risk patients who discontinued protocol therapy
Time from treatment discontinuation (months)
0
6
No. at risk
NIVO+IPI
352
98
69
46
34
22
5
SUN
383
42
23
13
8
2
0
12
18
24
18 months 24 months
30
100
75
50
25
0
36
Patients free from second-line treatment (%)
NIVO+IPI
SUN
TFS,
Months
TFS rate (95% CI), %
NIVO+IPI
(N = 352)
SUN
(N = 383)
18
20 (16–26)
6 (4–9)
24
19 (15–24)
6 (4–9)
McDermott, ESMO 2018